Cascade Investment Group Inc. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 20.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,916 shares of the company’s stock after selling 1,292 shares during the quarter. Cascade Investment Group Inc.’s holdings in Colgate-Palmolive were worth $477,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Hexagon Capital Partners LLC lifted its holdings in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after buying an additional 110 shares in the last quarter. RFG Advisory LLC grew its position in Colgate-Palmolive by 2.1% during the 2nd quarter. RFG Advisory LLC now owns 5,411 shares of the company’s stock worth $525,000 after purchasing an additional 112 shares during the last quarter. Legacy Trust grew its position in Colgate-Palmolive by 1.7% during the 1st quarter. Legacy Trust now owns 6,925 shares of the company’s stock worth $624,000 after purchasing an additional 116 shares during the last quarter. Checchi Capital Advisers LLC grew its position in Colgate-Palmolive by 1.5% during the 1st quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock worth $705,000 after purchasing an additional 118 shares during the last quarter. Finally, Regal Investment Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after acquiring an additional 121 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The disclosure for this sale can be found here. Insiders have sold 41,177 shares of company stock valued at $4,245,835 in the last quarter. Insiders own 0.34% of the company’s stock.
Analyst Ratings Changes
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock traded up $1.54 during trading hours on Wednesday, reaching $102.13. The company’s stock had a trading volume of 3,149,381 shares, compared to its average volume of 4,421,859. The stock has a market cap of $83.79 billion, a P/E ratio of 32.32, a price-to-earnings-growth ratio of 3.54 and a beta of 0.39. The company’s 50 day simple moving average is $97.81 and its 200 day simple moving average is $91.93. Colgate-Palmolive has a one year low of $67.62 and a one year high of $104.15. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.77 EPS. As a group, analysts expect that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.96%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Canada Bond Market Holiday: How to Invest and Trade
- Brinker International’s Price Dip is an Appetizing Entry Point
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks That Could Beat the September Blues
- What Are the U.K. Market Holidays? How to Invest and Trade
- Canopy Growth Stock: Can It Sustain Recent Gains?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.